These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12950164)

  • 1. Structure and dynamics of the lantibiotic mutacin 1140.
    Smith L; Zachariah C; Thirumoorthy R; Rocca J; Novák J; Hillman JD; Edison AS
    Biochemistry; 2003 Sep; 42(35):10372-84. PubMed ID: 12950164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus subtilis antibiotics: structures, syntheses and specific functions.
    Stein T
    Mol Microbiol; 2005 May; 56(4):845-57. PubMed ID: 15853875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
    Geng M; Smith L
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The solution structure of the lantibiotic gallidermin.
    Freund S; Jung G; Gutbrod O; Folkers G; Gibbons WA; Allgaier H; Werner R
    Biopolymers; 1991 May; 31(6):803-11. PubMed ID: 1932575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid method for extracting the antibiotic mutacin 1140 from complex fermentation medium yeast extract.
    Chaney N; Wilson-Stanford S; Kastrantas J; Dahal N; Smith L
    Can J Microbiol; 2009 Nov; 55(11):1261-6. PubMed ID: 19940934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.
    Novák J; Caufield PW; Miller EJ
    J Bacteriol; 1994 Jul; 176(14):4316-20. PubMed ID: 8021218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
    Escano J; Ravichandran A; Salamat B; Smith L
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
    Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
    FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.
    Qi F; Chen P; Caufield PW
    Appl Environ Microbiol; 2001 Jan; 67(1):15-21. PubMed ID: 11133423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional structure in lipid micelles of the pediocin-like antimicrobial peptide sakacin P and a sakacin P variant that is structurally stabilized by an inserted C-terminal disulfide bridge.
    Uteng M; Hauge HH; Markwick PR; Fimland G; Mantzilas D; Nissen-Meyer J; Muhle-Goll C
    Biochemistry; 2003 Oct; 42(39):11417-26. PubMed ID: 14516192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
    Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
    Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutacin H-29B is identical to mutacin II (J-T8).
    Nicolas G; Morency H; LaPointe G; Lavoie MC
    BMC Microbiol; 2006 Apr; 6():36. PubMed ID: 16626493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
    Escano J; Stauffer B; Brennan J; Bullock M; Smith L
    J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.
    Smith L; Novák J; Rocca J; McClung S; Hillman JD; Edison AS
    Eur J Biochem; 2000 Dec; 267(23):6810-6. PubMed ID: 11082191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.
    Meyer HE; Heber M; Eisermann B; Korte H; Metzger JW; Jung G
    Anal Biochem; 1994 Dec; 223(2):185-90. PubMed ID: 7887461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1.
    Nicolas GG; LaPointe G; Lavoie MC
    BMC Microbiol; 2011 Apr; 11():69. PubMed ID: 21477375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.